Lauric Acid Is an Inhibitor of Clostridium difficile Growth in Vitro and Reduces Inflammation in a Mouse Infection Model
Clostridium difficile is a Gram-positive, spore-forming anaerobic human gastrointestinal pathogen. C. difficile infection (CDI) is a major health concern worldwide, with symptoms ranging from diarrhea to pseudomembranous colitis, toxic megacolon, sepsis, and death. CDI onset and progression are most...
Main Authors: | Hsiao-Ting Yang, Jenn-Wei Chen, Jagat Rathod, Yu-Zhen Jiang, Pei-Jane Tsai, Yuan-Pin Hung, Wen-Chien Ko, Daniel Paredes-Sabja, I-Hsiu Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-01-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fmicb.2017.02635/full |
Similar Items
-
Comparative genomic analysis of Clostridium difficile ribotype 027 strains including the newly sequenced strain NCKUH-21 isolated from a patient in Taiwan
by: Haruo Suzuki, et al.
Published: (2017-11-01) -
Immunization with Recombinant TcdB-Encapsulated Nanocomplex Induces Protection against Clostridium difficile Challenge in a Mouse Model
by: Yi-Wen Liu, et al.
Published: (2017-07-01) -
Application of Microbiome Management in Therapy for <i>Clostridioides difficile</i> Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents
by: Chun-Wei Chiu, et al.
Published: (2021-05-01) -
The Transcriptional Regulator Lrp Contributes to Toxin Expression, Sporulation, and Swimming Motility in Clostridium difficile
by: Kuan-Yu Chen, et al.
Published: (2019-10-01) -
Doxycycline and Tigecycline: Two Friendly Drugs with a Low Association with Clostridium Difficile Infection
by: Yuan-Pin Hung, et al.
Published: (2015-06-01)